BMPR2 and cancer: XIAP inhibition of caspases promotes resistance to many cancer therapeutics including radiation, chemotherapeutics, and TRAIL [28, 35] The inhibition of BMPR2 decreases the expression of XIAP and inhibits the activity of TAK1 [20, 22, 46].